Featured,Trends & Articles Maryland Sends Bill to Fund Psychedelics Access by Veterans to Governor’s Desk By Dennis Mutua April 12, 2022 At the end of last week, legislators from Maryland send a bill which would create a state fund to fund cost-free access to psychedelics for military veterans suffering from brain injury and post-traumatic stress disorder (PTSD) to...
Psychedelic Stocks,Shroom News Cybin Applies for International PCT Patent for Inhalation Delivery of Multiple Psychedelics Molecules By Dennis Mutua April 11, 2022 Biopharmaceutical company focusing on advancing psychedelic pharmaceutical treatments for various psychiatric and neurological conditions Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) announced that the World Intellectual Property ...
Featured,Spotlight Stock,Trends & Articles Recent Study Shows People Who Have Used Magic Mushrooms Are Less Likely to Develop Opioid Use Disorder By Dennis Mutua April 08, 2022 A recently conducted study by researchers from Harvard University people who have used psilocybin specifically magic mushrooms at some point in their lives are 30% less likely to suffer from opioid use disorder compared to those w...
Psychedelic Stocks Oregon Psilocybin Draft Rules: Testing By Dennis Mutua April 07, 2022 On Friday, April 1, 2022 the Oregon Health Authority (OHA) released revised proposed Oregon Administrative Rules (OARs) for psilocybin services. These rules focus on psilocybin products, testing, and training programs. There will ...
Spotlight Stock,Trends & Articles Entheon Biomedical to Execute a Non-Brokered Private Placement Funding By Dennis Mutua April 07, 2022 Biotechnology company focused on research and development of psychedelic medicines to address addictions disorders and mental illnesses Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) announced that it will be moving forward w...
Psychedelic Stocks Free Oregon Psilocybin Webinar Tomorrow! OHA and Harris Bricken By Dennis Mutua April 06, 2022 Register HERE! Please join Harris Bricken lawyers Mason Marks and Vince Sliwoski as they team up with Angela Allbee of the Oregon Health Authority (OHA) for a lunch hour webinar on April 7. Angela, Mason and Vince will discuss upd...
Featured,Spotlight Stock,Trends & Articles Field Trip Receives US Patent for Novel Psychedelic Molecule FT-104 By Dennis Mutua April 06, 2022 Biotechnology company specializing on developing and delivering technology enabled psychedelic therapies Field Trip Health Ltd. (NASDAQ: FTRP) (TSX: FTRP) has been granted a patent for claims linked to FT-104, the company’s firs...
Psychedelic Stocks Oregon Psilocybin Draft Rules: Products By Dennis Mutua April 05, 2022 On Friday, April 1, 2022 the Oregon Health Authority (OHA) released revised proposed Oregon Administrative Rules (OARs) for psilocybin products, testing, and training programs. This post will focus on the rules related to products...